Achilles Therapeutics plc Quarterly Earnings Per Share, Basic in USD/shares from Q2 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Achilles Therapeutics plc quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2022 to Q2 2024.
  • Achilles Therapeutics plc Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.41 USD/shares, a 2.38% increase year-over-year.
  • Achilles Therapeutics plc annual Earnings Per Share, Basic for 2023 was -1.74 USD/shares, a 4.4% increase from 2022.
  • Achilles Therapeutics plc annual Earnings Per Share, Basic for 2022 was -1.82 USD/shares, a 14.6% increase from 2021.
  • Achilles Therapeutics plc annual Earnings Per Share, Basic for 2021 was -2.13 USD/shares, a 93.2% increase from 2020.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 +$0.01 +2.38% Apr 1, 2024 Jun 30, 2024 6-K 2024-08-14
Q2 2023 $0 +$0.02 +4.55% Apr 1, 2023 Jun 30, 2023 6-K 2024-08-14
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 6-K 2023-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.